Article Information
History
- August 18, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Nan Shen1,*,
- Nevenka Dimitrova2,*,
- Cleo H. Ho1,
- Pedro J. Torres1,
- Francine R Camacho1,
- Ying Cai1,
- Momchilo Vuyisich1,
- Damon Tanton3 and
- Guruduth Banavar1,#
- 1Viome Research Institute, Viome Inc, Seattle, WA and New York, NY, USA
- 2New York Medical College, Valhalla, New York, NY, USA
- 3Endocrinology, Diabetes And Metabolism, AdventHealth, Orlando, FL, USA
- ↵#Corresponding author: G.B. guru{at}viome.com
↵* These authors contributed equally to this work and should be considered co-first-authors.
Posted August 18, 2021.
Gut microbiome activity predicts risk of type 2 diabetes and metformin control in a large human cohort
